Minoxidil and Its Use in Hair Disorders: A Review [Corrigendum]
Suchonwanit P, Thammarucha S, Leerunyakul K. Drug Des Devel Ther. 2019;13:2777–2786. On page 2781, Androgenetic alopecia section, last paragraph, “A combination of low-dose minoxidil 2.5 mg and spironolactone 25 mg in patients with FPHL showed preferable outcomes with decrease ha...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-02-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | https://www.dovepress.com/corrigendum-minoxidil-and-its-use-in-hair-disord-peer-reviewed-article-DDDT |